709 related articles for article (PubMed ID: 25034931)
21. Role of postmastectomy radiation therapy after neoadjuvant chemotherapy in locally advanced breast cancer.
Akyurek S; Yavas G
Exp Oncol; 2013 Dec; 35(4):267-71. PubMed ID: 24382436
[TBL] [Abstract][Full Text] [Related]
22. [Option of the surgical mode for breast cancer based on the effect of neoadjuvant chemotherapy].
Fukutomi T
Nihon Geka Gakkai Zasshi; 2002 Nov; 103(11):803-5. PubMed ID: 12478855
[TBL] [Abstract][Full Text] [Related]
23. Surgical management of early stage invasive breast cancer: a practice guideline.
McCready D; Holloway C; Shelley W; Down N; Robinson P; Sinclair S; Mirsky D; ;
Can J Surg; 2005 Jun; 48(3):185-94. PubMed ID: 16013621
[TBL] [Abstract][Full Text] [Related]
24. Docetaxel followed by fluorouracil/epirubicin/cyclophosphamide as neoadjuvant chemotherapy for patients with primary breast cancer.
Iwata H; Sato N; Masuda N; Nakamura S; Yamamoto N; Kuroi K; Kurosumi M; Tsuda H; Akiyama F; Ohashi Y; Toi M
Jpn J Clin Oncol; 2011 Jul; 41(7):867-75. PubMed ID: 21719750
[TBL] [Abstract][Full Text] [Related]
25. Preoperative (neoadjuvant) systemic treatment of breast cancer.
Kaufmann M; von Minckwitz G; Rody A
Breast; 2005 Dec; 14(6):576-81. PubMed ID: 16199160
[TBL] [Abstract][Full Text] [Related]
26. Primary systemic chemotherapy for inflammatory breast cancer.
Sinclair S; Swain SM
Cancer; 2010 Jun; 116(11 Suppl):2821-8. PubMed ID: 20503414
[TBL] [Abstract][Full Text] [Related]
27. Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease.
Gralow JR; Burstein HJ; Wood W; Hortobagyi GN; Gianni L; von Minckwitz G; Buzdar AU; Smith IE; Symmans WF; Singh B; Winer EP
J Clin Oncol; 2008 Feb; 26(5):814-9. PubMed ID: 18258991
[TBL] [Abstract][Full Text] [Related]
28. [Neoadjuvant systemic therapy in patients with operable primary breast cancer: more benefits than breast-conserving therapy].
Straver ME; van Adrichem JC; Rutgers EJ; Rodenhuis S; Linn SC; Loo CE; Gilhuijs KG; Oldenburg HS; Wesseling J; Russell NS; Antonini N; Vrancken Peeters MT
Ned Tijdschr Geneeskd; 2008 Nov; 152(46):2519-25. PubMed ID: 19055260
[TBL] [Abstract][Full Text] [Related]
29. Pathologic complete response with six compared with three cycles of neoadjuvant epirubicin plus docetaxel and granulocyte colony-stimulating factor in operable breast cancer: results of ABCSG-14.
Steger GG; Galid A; Gnant M; Mlineritsch B; Lang A; Tausch C; Rudas M; Greil R; Wenzel C; Singer CF; Haid A; Pöstlberger S; Samonigg H; Luschin-Ebengreuth G; Kwasny W; Klug E; Kubista E; Menzel C; Jakesz R;
J Clin Oncol; 2007 May; 25(15):2012-8. PubMed ID: 17513805
[TBL] [Abstract][Full Text] [Related]
30. Recurrence rates after DCE-MRI image guided planning for breast-conserving surgery following neoadjuvant chemotherapy for locally advanced breast cancer patients.
Garimella V; Qutob O; Fox JN; Long ED; Chaturvedi A; Turnbull LW; Drew PJ
Eur J Surg Oncol; 2007 Mar; 33(2):157-61. PubMed ID: 17085007
[TBL] [Abstract][Full Text] [Related]
31. Impact of neoadjuvant chemotherapy on locoregional surgical treatment of breast cancer.
Mamounas EP
Ann Surg Oncol; 2015 May; 22(5):1425-33. PubMed ID: 25727558
[TBL] [Abstract][Full Text] [Related]
32. Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab.
Hsiang DJ; Yamamoto M; Mehta RS; Su MY; Baick CH; Lane KT; Butler JA
Arch Surg; 2007 Sep; 142(9):855-61; discussion 860-1. PubMed ID: 17875840
[TBL] [Abstract][Full Text] [Related]
33. A multidisciplinary approach to neoadjuvant therapy for primary operable breast cancer. Challenges and opportunities.
Connolly R; Stearns V
Oncology (Williston Park); 2010 Feb; 24(2):135-43. PubMed ID: 20361464
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
[TBL] [Abstract][Full Text] [Related]
35. Breast-conserving therapy after neoadjuvant chemotherapy: long-term results.
Beriwal S; Schwartz GF; Komarnicky L; Garcia-Young JA
Breast J; 2006; 12(2):159-64. PubMed ID: 16509842
[TBL] [Abstract][Full Text] [Related]
36. Breast-conserving surgery in the neoadjuvant setting.
Brenin DR; Morrow M
Semin Oncol; 1998 Apr; 25(2 Suppl 3):13-8. PubMed ID: 9566202
[TBL] [Abstract][Full Text] [Related]
37. Neoadjuvant chemotherapy for local advanced breast cancer with stage IIIB.
Kim R; Osaki A; Tanabe K; Toge T
Oncol Rep; 2004 Jun; 11(6):1265-72. PubMed ID: 15138565
[TBL] [Abstract][Full Text] [Related]
38. [Sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer].
Mátrai Z; Tóth L; Polgár C; Láng I; Gõdény M; Sinkovics I; Horváth Z; Bidlek M; Udvarhelyi N; Bartal A; Sávolt A; Ujhelyi M; Kásler M
Magy Onkol; 2011 Jun; 55(2):73-84. PubMed ID: 21655472
[TBL] [Abstract][Full Text] [Related]
39. Neoadjuvant therapy for breast cancer.
Liu SV; Melstrom L; Yao K; Russell CA; Sener SF
J Surg Oncol; 2010 Mar; 101(4):283-91. PubMed ID: 20187061
[TBL] [Abstract][Full Text] [Related]
40. Breast conservation following neoadjuvant therapy for breast cancer in the modern era: Are we losing the opportunity?
Criscitiello C; Curigliano G; Burstein HJ; Wong S; Esposito A; Viale G; Giuliano M; Veronesi U; Santangelo M; Golshan M
Eur J Surg Oncol; 2016 Dec; 42(12):1780-1786. PubMed ID: 27825710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]